Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment

US Patent 11497796 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →